Agarwal Vineet — SEC Form 4 filings

SEC reporting owner CIK 1997973. 3 Form 4 filings on record with FilingPulse; latest filed 2025-02-05.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-10-18 to 2025-02-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Korro Bio, Inc. (KRRO)Chief Financial Officer312 legs · 11,016 sh · $855,5277

Form 4 filings — Agarwal Vineet

FiledFormIssuerReported transactionsSource
2025-02-054Korro Bio, Inc. (KRRO)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-11-124Korro Bio, Inc. (KRRO)Option exercise (M): 800 @ $11.68 · Sale (S): 800 @ $70 · Option exercise (M): 800 (derivative) @ $0EDGAR
2024-10-184Korro Bio, Inc. (KRRO)Option exercise (M): 9,263 @ $11.68 · Option exercise (M): 953 @ $14.98 · Sale (S): 2,023 @ $71.51 · Sale (S): 164 @ $73.71 · Sale (S): 115 @ $74.56 · Sale (S): 56 @ $76 · +9 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1997973 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →